Product Description
CD160 is a GPI-anchored lymphocyte surface receptor in which expression is mostly restricted to the highly cytotoxic CD56(dim) CD16(+) peripheral blood NK subset. CD160 is a receptor showing broad specificity for both classical and non-classical MHC class I molecules. CD160 acts as a co-activator receptor for CD3-induced proliferation of CD4+ CD160+ T cells isolated from inflammatory skin lesions. CD160-Fc fusion protein targets a novel costimulatory pathway and prolongs allograft survival.
Biovision | P1110 | Human CellExp CD160 human recombinant DataSheet
Biomolecule/Target: CD160
Synonyms: Natural Killer Cell Receptor BY55, NK28, NK1
Alternates names: Placenta Growth Factor-2, PGFL
Taglines: N/A
NCBI Gene ID #: 5228
NCBI Gene Symbol: PGF
Gene Source: Human
Accession #: AAB30462
Recombinant: Yes
Source: CHO cells
Purity by SDS-PAGEs: 90%
Assay: SDS-PAGE
Purity: N/A
Assay #2: N/A
Endotoxin Level: < 0.06 EU/g
Activity (Specifications/test method): N/A
Biological activity: The PLFG-2 is fully biologically active when compared with standards. Recombinant human PIGF-2 can bind to immobilized rh-sFlt-1 (100 ng/well) with linear range at 0.3-10 ng/ml.
Results: 0.3-10 ng/ml
Binding Capacity: N/A
Unit Definition: N/A
Molecular Weight: 18.0 kDa
Concentration: N/A
Appearance: Lyophilized
Physical form description: Lyophilized from 0.2 m-filtered solution in PBS
Reconstitution Instructions: Reconstitute the protein in sterile 20 mM acetic acid to a concentration of 0.1-1.0 g/l. The solution can then be diluted into other aqueous buffer
Amino acid sequence: N/A